What happens after stem cell therapy? The follow-up, call by call

Follow-up after stem cell therapy at Celva is a call at 1 week, then at 1, 3 and 6 months, then once a year. Your patient coordinator or aftercare specialist makes each call, by phone or video, and a physician joins when needed. The schedule is the same for every treated patient, and it's included.

See what happens on each call
Your patient coordinator or aftercare specialist calls By phone or video. A physician joins when needed

Why follow up after treatment at all?

Most regenerative-medicine clinics end the relationship at the airport. The infusion is on Tuesday, the discharge papers go home in your bag, and the next time anyone calls is when a marketing email asks if you want to come back.

We don't operate that way. Partly because it would be irresponsible, and partly because we can't improve a protocol whose outcomes we don't track.

When are the follow-up calls after stem cell therapy?

The follow-up cadence below is what every treated patient gets by default. It's not a premium add-on. The dates live on our calendar, not your fridge. Each call has a defined purpose and a defined record. Your patient coordinator or aftercare specialist makes every call, by phone or video, and a physician joins when needed. If you read only one of these, read month 3. Press play to walk through, or click any point on the rail.

Week 1

Safety check first contact home.

The first call after you are home. Your patient coordinator or aftercare specialist confirms you are safe: no adverse events, no infusion-site reaction, sleep recovering, basic recovery on track. The goal isn't to assess response; it's to catch anything that shouldn't go unaddressed.

If anything is off, it goes to the physician team within the same business day.

  • Adverse events
  • Infusion site
  • Sleep
  • Triage path
Owner
Coordinator or aftercare specialist
Channel
Phone or video
Duration
15 min
Record
Chart note

Month 1

Early response first signal.

The first conversation about response. Pain, sleep, mobility, mood. We're looking for early signal, and for any expectations that need to be re-set before they harden into disappointment.

Most response is gradual; some patients see early shifts, some don't. The job at this call is to read the early signs honestly, not to oversell them. A physician joins when needed.

  • Pain
  • Mobility
  • Medications
  • Expectations
Owner
Coordinator or aftercare specialist
Channel
Phone or video
Duration
30 min
Record
Chart note

Month 3

The first real read three months in.

The call that matters most for most indications. How the pain and function are actually tracking. Labs you get on your own can be passed to the medical team. This is where most of the year's "is it working?" answer comes from.

The month-3 read is what we compare against at month 6 and at each yearly call. Same questions, same patient, same record.

  • Function
  • Quality of life
  • Medications
  • Your own labs
Owner
Coordinator or aftercare specialist
Channel
Phone or video
Duration
30 min
Record
Full check-in

Month 6

Six-month review are gains holding?

Trajectory check. Are the gains we saw at month-3 holding? Any drift in scores, in medication, in daily function?

This is the review that decides what happens next. Whether a second treatment makes sense is decided at your follow-up reviews, and this is the place where we say "not yet" or "not indicated" if the record doesn't support it.

  • Progress check
  • Trajectory
  • Medications
  • What happens next
Owner
Coordinator or aftercare specialist
Channel
Phone or video
Duration
30 min
Record
Trajectory note

Every year

Yearly check-in for good.

Once a year, every year. After month 6 the calls do not stop; they settle to one a year, the first around month 12. We read where you are against the year before: holding, drifting, or fading. For a few patients it is where a slow regression gets caught.

Whether a further treatment makes sense is decided at these reviews.

  • Progress check
  • Trajectory
  • Next step
  • Regression watch
Owner
Coordinator or aftercare specialist
Channel
Phone or video
Duration
30 min
Record
Trajectory note
Read the recovery timeline, week 1 through month 12 and beyond

What gets asked on each call?

The cadence is the same for everyone. What comes up on each call is not. Safety and your primary symptom come up every time. Function and quality of life come up when your condition calls for them, not on a fixed rule. Celva does not schedule labs or imaging: labs you get on your own can be passed to the medical team. Hover a domain row or a timepoint column to see how they intersect.

  • Filled dot = every relevant call.
  • Light dot = discussed as needed.
  • Blue ring = when it fits your case.
  • Open dot = not part of that call.

Whatever we follow for you, we follow it the same way each time. That's how a real change is told apart from a memory effect.

DomainWeek 1Month 1Month 3Month 6Every year
Adverse events & safetyReactions · hospitalization · infectionEvery callEvery callEvery callEvery callEvery call
PainHow much it hurts, in your wordsDiscussedEvery callEvery callEvery callEvery call
FunctionWhat you can do again · when your case fitsNot in callWhen it fitsWhen it fitsWhen it fitsWhen it fits
Quality of lifePhysical + mental · when your case fitsNot in callWhen it fitsWhen it fitsWhen it fitsWhen it fits
Sleep & moodBrief screening · flagged for follow-upDiscussedDiscussedDiscussedDiscussedDiscussed
Medication changesOn / off / dose-changed since treatmentDiscussedEvery callEvery callEvery callEvery call
Your own labsResults you had done yourself · passed to the medical teamNot in callNot in callWhen it fitsWhen it fitsWhen it fits

How do we tell whether the treatment is working?

"How are you feeling?" is the first question and a useful one. It is also the only question some clinics ask. The follow-up program captures both, what you tell us and what the medical team reads, because they answer different questions, and the gap between them is itself a signal.

What the patient tells us

  • How much it hurtsIn your own words, across your main symptom.Subjective · high signal for the patient's own experience
  • Activities of daily livingStairs, sleep, time on feet, exercise return.Context · what you can do week to week
  • Mood & satisfactionBrief screening; flagged if it shifts.A signal in its own right · not a treatment outcome
  • Free-text feedbackThe "what surprised you" and "what didn't" notes.Mined for protocol-improvement themes

What the medical team reads

  • FunctionWhat you can do again: stairs, reach, distance, time on your feet.Read the same way each call
  • Quality of lifeHow you're sleeping, moving, and feeling overall.Read the same way each call
  • Your own labsResults you have had done on your own, passed to the medical team.Not scheduled by Celva · read when you send them

Reported and measured are both real. They diverge sometimes: a patient who feels better with a score that hasn't moved, or a score that has moved with a patient who hasn't noticed. The divergence is interesting, not a problem. It is the conversation at month 6.

Where do your answers go after the call?

The follow-up data isn't filed in a drawer. De-identified outcomes are reviewed quarterly, fed back into the treating protocol, and shape what we recommend to the next patient with the same indication. Click any step.

Capture at the call.

Symptoms and function, adverse events, medication changes, free-text notes, recorded in the integrated chart, not a separate spreadsheet.

Aggregate by cohort.

De-identified data grouped by indication, dose, source, age range. Quarterly the team reviews the cohort signal, not single anecdotes.

Decide what changes.

Our physicians review and propose protocol changes: dose adjustments, candidate criteria, follow-up frequency. Decisions documented.

Apply to the next patient.

Updated protocol applied to subsequent intake. The patient at month-12 helped shape the consent the patient at month-0 is signing.

Does follow-up end after the first year?

The infusion is one day. The relationship is a lifetime.

The structured year is where the relationship starts, not where it ends. For a joint, the aim is relief that holds, and whether a second treatment makes sense is decided at your follow-up reviews. Stem cells are not a cure, and we will not pretend otherwise.

For a neurodegenerative, autoimmune, or complex case the goal is different: quality of life, because we are managing a condition, not erasing it. Whether a further treatment makes sense is decided at review. Either way, the door does not close in December. The relationship is the data, and the data is the protocol.